SCHEMBL1156784

SCHEMBL1156784

Cc1c(NCl)sc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.44
ALDH1A1 P00352 3/20 0.40
RXFP1 Q9HBX9 2/20 0.39
PRNP P04156 1/20 0.39
MAPT P10636 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
ATM Q13315 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ROCK1 Q13464 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23009381 0.82 GPR3 (0.46) GPR3ALDH1A1RXFP1PRNPMAPT
SCHEMBL15933912 0.78 LOXL2 (0.50) GPR3ALDH1A1RXFP1MAPTKMT2A
SCHEMBL18088620 0.74 KEAP1 (0.42) GPR3ALDH1A1RXFP1PRNPROCK1
SCHEMBL9407733 0.72 GPR3 (0.50) GPR3ALDH1A1RXFP1PRNPMAPT
SCHEMBL144440 0.72 GPR3 (0.55) GPR3ALDH1A1RXFP1PRNPMAPT
Ammonia Solution, Strong SCHEMBL28459123 0.70 GPR3 (0.52) GPR3ALDH1A1RXFP1PRNPMAPT
SCHEMBL1100006 0.70 CA2 (0.39) GPR3ALDH1A1RXFP1PRNPSMN1; SMN2
SCHEMBL16586080 0.70 PRNP (0.44) ALDH1A1RXFP1PRNPMAPTKMT2A
SCHEMBL5295130 0.68 GPR3 (0.50) GPR3ALDH1A1RXFP1PRNPMAPT
SCHEMBL16900681 0.68 GPR3 (0.50) GPR3ALDH1A1RXFP1PRNPMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed
WO-2009012430-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 GPR3 109/4885ALDH1A1 3091/4885RXFP1 512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.